Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Department of Systems Medicine, University "Tor Vergata" of Rome, 00133 Rome, Italy.
Int J Mol Sci. 2024 Nov 14;25(22):12232. doi: 10.3390/ijms252212232.
Heart failure (HF) is a complex condition that affects 1-2% of the global population. The presence of comorbidities like diabetes, hypertension, hyperlipidemia, or obesity has been shown in various studies to elevate mortality and hospitalization rates in HF patients. Insufficient outcomes persist in HF, necessitating additional research to address unmet needs in disease management. Lifestyle modifications, including smoking cessation, decreased alcohol consumption, regular exercise, cardiac rehabilitation, and a balanced diet, can prevent and treat a wide range of HF cases. In this review, we aimed to examine how lifestyle changes, nutrition, and nutraceutical supplements can play a role in preventing heart failure and supporting its treatment. A detailed and comprehensive analysis of the most recent data present in the literature could help identify potential candidates for future clinical trials in HF management. There is a growing body of evidence supporting the importance of closely monitoring nutritional balance, including micronutrients and nutraceuticals, in HF patients for better symptom management and outcomes. Despite promising results from initial approaches, the lack of conclusive evidence from recent studies and meta-analyses questions the widespread use of nutraceutical supplementation in HF patients. Further studies are necessary to determine the most effective way to use nutraceutical supplementation in the treatment of myocardial dysfunction in HF patients.
心力衰竭(HF)是一种影响全球 1-2%人口的复杂疾病。多项研究表明,糖尿病、高血压、高血脂或肥胖等合并症的存在会增加 HF 患者的死亡率和住院率。HF 的预后仍然不理想,需要进一步研究以解决疾病管理中的未满足需求。生活方式的改变,包括戒烟、减少饮酒、规律运动、心脏康复和均衡饮食,可以预防和治疗多种 HF 病例。在本次综述中,我们旨在探讨生活方式的改变、营养和保健品如何在预防心力衰竭和支持其治疗中发挥作用。对文献中最新数据进行详细和全面的分析,有助于确定 HF 管理未来临床试验的潜在候选药物。越来越多的证据表明,密切监测 HF 患者的营养平衡(包括微量营养素和保健品)对于更好地控制症状和改善预后非常重要。尽管初步方法取得了有希望的结果,但最近的研究和荟萃分析缺乏确凿的证据,这使得在 HF 患者中广泛使用保健品补充剂的做法受到质疑。需要进一步的研究来确定在 HF 患者心肌功能障碍的治疗中使用保健品补充剂的最有效方法。